全文获取类型
收费全文 | 37404篇 |
免费 | 2121篇 |
国内免费 | 1158篇 |
专业分类
耳鼻咽喉 | 351篇 |
儿科学 | 691篇 |
妇产科学 | 1138篇 |
基础医学 | 8930篇 |
口腔科学 | 929篇 |
临床医学 | 2778篇 |
内科学 | 3622篇 |
皮肤病学 | 537篇 |
神经病学 | 1922篇 |
特种医学 | 1175篇 |
外国民族医学 | 6篇 |
外科学 | 4002篇 |
综合类 | 4360篇 |
预防医学 | 3617篇 |
眼科学 | 480篇 |
药学 | 3574篇 |
15篇 | |
中国医学 | 499篇 |
肿瘤学 | 2057篇 |
出版年
2023年 | 413篇 |
2022年 | 689篇 |
2021年 | 1010篇 |
2020年 | 1073篇 |
2019年 | 960篇 |
2018年 | 992篇 |
2017年 | 1062篇 |
2016年 | 1042篇 |
2015年 | 1153篇 |
2014年 | 2210篇 |
2013年 | 2344篇 |
2012年 | 1904篇 |
2011年 | 2369篇 |
2010年 | 1826篇 |
2009年 | 1891篇 |
2008年 | 1897篇 |
2007年 | 1844篇 |
2006年 | 1639篇 |
2005年 | 1403篇 |
2004年 | 1212篇 |
2003年 | 1144篇 |
2002年 | 866篇 |
2001年 | 830篇 |
2000年 | 751篇 |
1999年 | 690篇 |
1998年 | 645篇 |
1997年 | 617篇 |
1996年 | 610篇 |
1995年 | 638篇 |
1994年 | 581篇 |
1993年 | 476篇 |
1992年 | 459篇 |
1991年 | 390篇 |
1990年 | 348篇 |
1989年 | 320篇 |
1988年 | 284篇 |
1987年 | 231篇 |
1986年 | 196篇 |
1985年 | 263篇 |
1984年 | 259篇 |
1983年 | 165篇 |
1982年 | 157篇 |
1981年 | 149篇 |
1980年 | 127篇 |
1979年 | 119篇 |
1978年 | 84篇 |
1977年 | 75篇 |
1976年 | 61篇 |
1974年 | 40篇 |
1973年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
目的探讨不同转化生长因子-β(TGF-β)表达量的人羊膜间充质干细胞(hAMSCs)尾静脉移植对异种周围神经移植小鼠坐骨神经功能的恢复作用。方法从健康剖宫产产妇志愿捐献的新鲜羊膜中分离出hAMSCs,并进行纯化及鉴定。构建上调和下调TGF-β表达的慢病毒质粒,并转染纯化的hAMSCs,构建出稳定的上调或下调TGF-β表达的hAMSCs。分离并剪去C57BL/6小鼠的部分坐骨神经,将SD大鼠的坐骨神经分离剪取并移植至小鼠的坐骨神经缺损处,构建出异种周围神经移植小鼠模型。将模型小鼠按随机数字表分为对照组、未修饰的hAMSCs治疗组、高表达TGF-β的hAMSCs治疗组、低表达TGF-β的hAMSCs治疗组,每组10只。各组于造模前1 d分别经尾静脉注射磷酸盐缓冲液或相应的hAMSCs重悬液进行移植治疗。于治疗后第14天时采用DigGait步态分析系统评估各组小鼠的坐骨神经功能恢复情况。结果治疗后第14天时,高表达TGF-β的hAMSCs治疗组小鼠的坐骨神经功能指数(-25.820±0.286)明显高于低表达TGF-β的hAMSCs治疗组(-33.413±0.920)和未修饰的hAMSCs治疗组(-30.755±0.421),差异均有统计学意义(P<0.05)。结论高表达TGF-β的hAMSCs尾静脉移植能够更有效地改善异种周围神经移植小鼠的坐骨神经功能,其可能成为周围神经损伤治疗的新突破口。 相似文献
73.
74.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):150-154.e2
Thoracic endovascular aortic repair (TEVAR) for aneurysmal chronic dissection is often complicated by retrograde filling of the false lumen and dissected distal landing zone. A “cheese wire”-style fenestration of the dissection intimal flap can create a landing zone facilitating TEVAR. This technique successfully aided TEVAR in 3 patients with an average age of 57.3 years. Complications included type III endoleak requiring relining and renal artery occlusion requiring stent placement. Average duration of clinical follow-up was 19 ± 4 months. Imaging follow-up was 8 ± 10 months. All patients have survived for more than 1 year without aneurysm enlargement. 相似文献
75.
76.
IntroductionCentral venous catheter applications and complications are closely related to the tip position. Previous studies have reported some rare cases of catheter misplacement. Here, we report a case of misplacement of a peripherally inserted central catheter into the lateral thoracic vein.Case reportA 56-year-old cancer patient underwent placement of a peripherally inserted central catheter through the left basilic vein under ultrasound-guided puncture. The catheterisation procedure was uneventful, so the catheter was believed to be in the superior vena cava. However, the post-anterior chest X-ray image revealed that after the catheter advanced towards the axilla, it turned downwards and outwards in the direction of the left lateral thoracic region, with the projection of the catheter tip giving the appearance of termination in the subcutaneous tissue of the lateral thoracic wall on the two-dimensional image. The catheter was then repositioned in the distal superior vena cava.DiscussionPeripherally inserted central catheters can be potentially misplaced into the lateral thoracic vein because these catheters can pass through the orifice of the lateral thoracic vein which flows into the axillary vein. Some pathological cases and clinical conditions can cause dilatation of the lateral thoracic vein, which increases the probability of catheter misplacement. Three principles were proposed to avoid this rare complication: a comprehensive review of the patients’ medical history, real-time image-guided catheterisation and routine radiographic identification of the tip position. 相似文献
77.
Eunice Sirri Joachim Kieschke Claudia Vohmann Alexander Katalinic Alice Nennecke Meike Ressing Andrea Eberle Bernd Holleczek Lina Jansen Hermann Brenner for the GEKID Cancer Survival Working Group 《International journal of cancer. Journal international du cancer》2020,147(6):1548-1558
Evidence on survival of malignant mesothelioma (MM) and other rare thoracic cancers is limited due to the rarity of these cancer sites. Here, we provide a comprehensive overview of MM incidence and survival after MM and other rare thoracic cancers in Germany and the United States (US). Incidence was estimated from a German National Cancer Database and from the Surveillance, Epidemiology and End Results (SEER) 18 database for 2000–2014. Patients diagnosed in 1997–2013 with malignant epithelial tumors of the trachea (Etra), epithelial tumors of the thymus (Ethy) and MM were extracted from a German cancer survival database and from the SEER 13 database. Period analysis was employed to compute 5-year relative survival (RS). During 2000–2014, an annual average of 0.9 and 0.6 MM cases per 100,000 person-years was diagnosed in Germany and the US. Rates decreased in Germany and in the US. Patients with Ethy had highest 5-year RS with US patients surviving longer (69.1% compared to 63.7%, p = 0.02). Survival after Etra was comparable in both countries (Germany 33.6%, US 34.4%, p = 0.07). Survival in MM patients was poor overall (Germany 11.8%, US 12.1%, p < 0.01). Survival improvements were only observed in MM patients in Germany (10.8% [2002–2007] vs. 13.0% [2008–2013], p < 0.01). The lack of progress in survival for Etra and Ethy patients underlines the need of novel preventive, therapeutic and diagnostic approaches. MM incidence significantly decreased in Germany and in the US. Further monitoring of MM incidence is warranted given that a peak in incidence is expected in 2020–2030 in Western countries. 相似文献
78.
《Clinical lung cancer》2020,21(4):e302-e314
BackgroundThe programmed death 1/programmed death-ligand 1 (PD-L1) pathway reportedly is as an important factor determining effects of immunotherapy; however, its prognostic impact is controversial, and its association with the surrounding immune microenvironment has not yet been elucidated.Patients and MethodsWe retrospectively analyzed 126 patients with pathologic stage I non–small-cell lung cancer. Patients with lepidic-dominant adenocarcinoma were excluded. PD-L1 expression was evaluated with immunohistochemistry correlated with clinicopathologic features and surrounding immune microenvironment status, including CD4, CD8, regulatory T cells, and human leukocyte antigen class I. Factors affecting prognosis were assessed by Kaplan-Meier and Cox regression analyses.ResultsTwenty-three (18.3%) patients were positive for PD-L1 expression. No significant correlation was observed between PD-L1 expression and the surrounding immune microenvironment status. The PD-L1–positive group had a worse prognosis than the PD-L1–negative group (5-year recurrence-free survival rates, 63.4% vs. 81.0%; P = .061). Among surrounding immune cells, intratumoral CD8 status had the strongest impact on prognosis (P = .12). In the intratumoral CD8–high group, PD-L1 expression demonstrated no significant prognostic impact, whereas in the intratumoral CD8–low group, patients positive for PD-L1 demonstrated a significantly worse prognosis than those negative for PD-L1 (5-year recurrence-free survival rates, 41.7% vs. 78.6%; P = .034). Multivariable Cox regression analysis revealed that ‘PD-L1–positive and intratumoral CD8–low’ status was an independent prognostic factor (hazard ratio, 3.80; 95% confidence interval, 1.22-10.5; P = .023).ConclusionsThe prognostic impact of the PD-1/PD-L1 pathway may be distinct according to concurrent intratumoral CD8 status. 相似文献
79.
目的:研究补肾凉血安胎法治疗肾虚血热型先兆流产合并宫腔积液的效果。方法:选择肾虚血热型先兆流产合并宫腔积液患者160例,按随机数字表法分为对照组和观察组各80例。对照组给予黄体酮联合酚磺乙胺治疗,观察组采用补肾凉血安胎法治疗,连续治疗2周。观察2组临床疗效,比较2组孕酮(P)、雌二醇(E2)、人绒毛膜促性腺激素(HCG),以及中医症候评分。结果:观察组总有效率为85.00%,高于对照组70.00%(P<0.05)。治疗前,2组P、HCG、E2水平比较,差异无统计学意义(P>0.05)。治疗后,2组P、HCG、E2水平较治疗前升高(P<0.05),且观察组P、HCG、E2水平高于对照组(P<0.05)。治疗前,2组各项中医症状评分比较,差异无统计学意义(P>0.05)。治疗后,2组各项中医症状评分较治疗前降低(P<0.05),且观察组各项中医症状评分低于对照组(P<0.05)。结论:采用补肾凉血安胎汤治疗肾虚血热型先兆流产合并宫腔积液患者,不仅能改善患者血液指标,有利于保胎,还能促进宫腔积液的吸收,效果显著,值得临床应用。 相似文献
80.
Asim Ghaffar Abbas A. Dehghani-Sanij Sheng Quan Xie 《Disability and rehabilitation. Assistive technology》2020,15(3):256-270
AbstractPurpose: Ambulation is an important objective for people with pathological gaits. Exoskeleton robots can assist these people to complete their activities of daily living. There are exoskeletons that have been presented in literature to assist the elderly and other pathological gait users. This article presents a review of the degree of support required in the elderly and neurological gait disorders found in the human population. This will help to advance the design of robot-assisted devices based on the needs of the end users.Methods: The articles included in this review are collected from different databases including Science Direct, Springer Link, Web of Science, Medline and PubMed and with the purpose to investigate the gait parameters of elderly and neurological patients. Studies were included after considering the full texts and only those which focus on spatiotemporal, kinematic and kinetic gait parameters were selected as they are most relevant to the scope of this review. A systematic review and meta-analysis were conducted.Results: The meta-analysis report on the spatiotemporal, kinematic and kinetic gait parameters of elderly and neurological patients revealed a significant difference based on the type and level of impairment. Healthy elderly population showed deviations in the gait parameters due to age, however, significant difference is observed in the gait parameters of the neurological patients.Conclusion: A level of agreement was observed in most of the studies however the review also noticed some controversies among different studies in the same group. The review on the spatiotemporal, kinematics and kinetic gait parameters will provide a summary of the fundamental needs of the users for the future design and development of robotic assistive devices.
- Implications for rehabilitation
The support requirements provide the foundation for designing assistive devices.
The findings will be crucial in defining the design criteria for robot assistive devices.